Skip to main content

Table 5 Barriers reported by pharmacies not providing a clozapine supply service (n = 122)a

From: Implementing a clozapine supply service in Australian community pharmacies: barriers and facilitators

Barriers to service implementation b

n

%

Lack of need for service (e.g. no clozapine consumers)

70

57.4

Limited knowledge of monitoring requirements

32

26.2

Clozapine has difficult supply arrangements

27

22.1

Limited financial return

25

20.5

Lack of time

23

18.9

Lack of access to training

22

18.0

Lack of external support or assistance

19

15.6

Increased resource requirements

18

14.8

Poor communication about regulatory changes

16

13.1

Difficulties in communication with prescribers

13

10.7

Do not believe clozapine should be supplied in the community

6

4.9

Other c

24

19.7

  1. a 122 respondents answered these questions; b Multiple responses allowed; c Other: included no information on how to implement the service, issues in implementing the service or unaware of the service